APA (7th ed.) Citation

R, P., S, P., J, N., JW, F., F, G., M, M., . . . BM, B. (2014). Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: Results from a Phase III study. Clinical endocrinology, 81(3), 408. https://doi.org/10.1111/cen.12431

Chicago Style (17th ed.) Citation

R, Pivonello, et al. "Pasireotide Treatment Significantly Improves Clinical Signs and Symptoms in Patients with Cushing's Disease: Results from a Phase III Study." Clinical Endocrinology 81, no. 3 (2014): 408. https://doi.org/10.1111/cen.12431.

MLA (9th ed.) Citation

R, Pivonello, et al. "Pasireotide Treatment Significantly Improves Clinical Signs and Symptoms in Patients with Cushing's Disease: Results from a Phase III Study." Clinical Endocrinology, vol. 81, no. 3, 2014, p. 408, https://doi.org/10.1111/cen.12431.